The High Court has upheld appeals in class actions against Ford and Toyota over the calculation of damages for reduction in value of defective vehicles.
A class action against Virgin Australia wants to drag Velocity Rewards into the case, claiming the frequent flyer program was involved in misleading investors about $460 million in funds on Virgin’s balance sheet.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
A judge has signed off on a class action settlement that will see Retail Food Group pay nothing to the current and former franchisees of its Michel’s Patisserie chain.
Johnson Winter Slattery has bolstered the ranks of its industrial relations and employment team, luring a new partner and special counsel away from Corrs Chambers Westgarth.
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
Years of hard fought litigation by axed Qantas ground crew and generic drug maker Sandoz ended in victory this week, thanks to legal eagles from Maurice Blackburn and Ashurst and their counsel. The week opened with a bang with a decision from Federal Court Justice Michael Lee in three landmark test cases by the Transport…
The scope of protection for geographical indications will be at issue in India’s appeal of a decision that barred it from registering a trade mark for basmati rice.